From Student to AML Patient in Days, Maddie’s Story Shows Why Trials Matter
After relapsing with leukaemia, Maddie aged 24, was out of options—except for one. A clinical trial gave her hope.
Make a Donation
Why donate?
Every single penny raised and donated to Cure Leukaemia goes straight back into funding clinical trials and research, through the Trials and Acceleration Programme (TAP).
The aim of these clinical trials is to not only find better, more effective, and kinder treatments for leukaemia, but it also connect patients to potentially life-saving treatments.
With donations and funding, clinical trials can work to create better treatment for blood cancer patients.
In the UK, someone is diagnosed with blood cancer every 14 minutes.
There are currently 250,000 people living with blood cancer in the UK.
Adrians Story
Adrian Penn talks about how he felt when he was diagnosed with leukaemia, and about his journey.
Adrian was first diagnosed with AML back in 2018. He has since bravely fought off the cancer after treatment at Birmingham’s Centre for Clinical Haematology.
Looking for other ways you can help?
There’s plenty of other ways to get involved and help – from fundraising on your own, to taking part in one of our events.
Read more patients stories
Sara’s ALL Diary – Part 4
Diary of Sara, an Acute Lymphoblastic Leukaemia (ALL) Patient.
Raising Awareness on World Blood Cancer Day
On World Blood Cancer Day, we stand in solidarity with patients, families, researchers, and healthcare professionals who are fighting to change that.
Rob’s Experience in a CAR-T Trial
After living cancer-free for 15 years, Rob faced two devastating relapses of stage 4 lymphoma. The thought of enduring another six months of chemotherapy was overwhelming — until he was offered a place on the ZUMA-22 clinical trial, exploring the use of CAR-T cell therapy for relapsed lymphoma patients.